Predicting tumor spread using MRI in sarcoma or bone cancer
Part of Cancer clinical trials.
This trial uses MRI scans to create a model that may predict if a musculoskeletal tumor is spreading. It aims to help doctors decide on the best surgical treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a suspected soft tissue sarcoma or bone cancer tumor that needs surgery
- You are able to have an MRI with contrast dye and understand the study
- You do not have another cancer or have had cancer in the last 5 years
- You do not have serious health issues that would make the MRI unsafe (like kidney failure, allergies to the dye, claustrophobia, epilepsy, or implants not safe for MRI)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer way of giving radiation (spatially fractionated) compared to standard radiation for people with large soft tissue sarcomas. It aims to see if the new method works better.
This trial is testing a new way to use MRI scans to find breast cancer that has spread to other parts of the body early. It is for people who have had aggressive breast cancer (HER2 positive or triple negative) and finished treatment with surgery, but still have a higher risk of the cancer coming back.
This study aims to create new laboratory models to better understand sarcomas and cancers that have spread to the bone or lungs. By using donated tumor tissue and blood, researchers hope to learn how these cancers grow and develop, which could lead to better treatments in the future.
This study tests a new MRI-based technique to better see the size and shape of bone sarcomas before surgery. The goal is to help surgeons remove all the cancer while saving as much healthy bone as possible.
This trial studies new imaging methods to better identify and stage (find how far it has spread) suspected bone or soft-tissue tumors. It may help your care team choose the most accurate next steps based on your scans.
This trial tests a new blood-test technology to find and study cancer cells in people with advanced soft tissue sarcoma. It aims to improve how we track the disease and guide treatment decisions.
Hear when a new Soft Tissue Sarcoma (STS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.